Skip to content

Envoy Medical COCH Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$234K-2.9%$241K+15.9%$208K-6.3%$222K+4.7%$212K-5.8%
$961K+10.0%$874K+6.6%$820K+2.0%$804K-1.3%$815K+9.8%
-$727K-14.8%-$633K-3.4%-$612K-5.2%-$582K+3.5%-$603K-16.6%
-310.7%-48.0pp-262.7%+31.6pp-294.2%-32.1pp-262.2%+22.3pp-284.4%-54.7pp
$13.38M+7.2%$12.49M+20.0%$10.4M-0.5%$10.46M-1.0%$10.57M+3.8%
$1.03M-15.9%$1.22M-25.7%$1.64M+0.7%$1.63M-7.7%$1.77M+1.9%
$7.99M+0.7%$7.93M+2.0%$7.78M+10.7%$7.02M+7.4%$6.54M-4.2%
$23.36M+3.8%$22.51M+9.1%$20.64M+3.6%$19.92M+1.2%$19.69M+1.1%
-$23.12M-3.8%-$22.27M-9.0%-$20.43M-3.7%-$19.7M-1.1%-$19.48M-1.2%
-9,881.2%-641pp-9,240.7%+583pp-9,824%-951pp-8,873%+316pp-9,188.7%-630pp
$1.59M-19.5%$1.97M+11.7%$1.77M+38.6%$1.28M+56.3%
$13K+101%-$1.49M-9.7%-$1.35M+13.6%-$1.57M-3,547%-$43K+97.2%
-$23.11M+2.7%-$23.76M-9.0%-$21.79M-2.5%-$21.27M-8.9%-$19.52M+6.1%
-9,875.6%-18.4pp-9,857.3%+618pp-10,475%-896pp-9,579.3%-370pp-9,209%+33.3pp
-$1.01+17.2%-$1.22+10.3%-$1.36+2.9%-$1.40-2.2%-$1.37+8.1%
-$22.81M-3.8%-$21.97M-8.9%-$20.16M-3.6%-$19.46M-0.9%-$19.28M-1.0%
-9,747%-632pp-9,115.4%+579pp-9,694.2%-931pp-8,763.5%+331pp-9,094.3%-613pp
-$23.12M-3.8%-$22.27M-9.0%-$20.43M-3.7%-$19.7M-1.1%-$19.48M-1.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Envoy Medical's revenue?
Envoy Medical (COCH) generated $234.0K in revenue over the trailing twelve months, up 10.4% year over year.
Is Envoy Medical profitable?
Envoy Medical is not currently profitable: it reported a net loss of $23.1M over the trailing twelve months, a -9875.6% net margin.
What are Envoy Medical's profit margins?
Gross margin is -310.7% and operating margin is -9881.2%, with a -9875.6% net margin.
What is Envoy Medical's earnings per share?
Envoy Medical's diluted EPS over the trailing twelve months is $-1.01.
Where does Envoy Medical's income statement data come from?
Every line is extracted from Envoy Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.